1-236744711-C-T

Variant summary

Our verdict is Benign. The variant received -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2

The NM_001103.4(ACTN2):​c.1341C>T​(p.Phe447Phe) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00251 in 1,614,164 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0021 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0026 ( 8 hom. )

Consequence

ACTN2
NM_001103.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:15

Conservation

PhyloP100: -0.299

Publications

4 publications found
Variant links:
Genes affected
ACTN2 (HGNC:164): (actinin alpha 2) Alpha actinins belong to the spectrin gene superfamily which represents a diverse group of cytoskeletal proteins, including the alpha and beta spectrins and dystrophins. Alpha actinin is an actin-binding protein with multiple roles in different cell types. In nonmuscle cells, the cytoskeletal isoform is found along microfilament bundles and adherens-type junctions, where it is involved in binding actin to the membrane. In contrast, skeletal, cardiac, and smooth muscle isoforms are localized to the Z-disc and analogous dense bodies, where they help anchor the myofibrillar actin filaments. This gene encodes a muscle-specific, alpha actinin isoform that is expressed in both skeletal and cardiac muscles. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2013]
ACTN2 Gene-Disease associations (from GenCC):
  • ACTN2-related cardiac and skeletal myopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • myopathy, congenital, with structured cores and z-line abnormalities
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • dilated cardiomyopathy 1AA
    Inheritance: AD Classification: MODERATE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • intrinsic cardiomyopathy
    Inheritance: AD Classification: MODERATE Submitted by: Laboratory for Molecular Medicine
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • heart conduction disease
    Inheritance: AD Classification: LIMITED Submitted by: Genomics England PanelApp
  • myopathy, distal, 6, adult-onset, autosomal dominant
    Inheritance: AD, Unknown Classification: LIMITED Submitted by: Broad Center for Mendelian Genomics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -15 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.26).
BP6
Variant 1-236744711-C-T is Benign according to our data. Variant chr1-236744711-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 43902.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.299 with no splicing effect.
BS2
High AC in GnomAd4 at 320 AD,Unknown gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001103.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ACTN2
NM_001103.4
MANE Select
c.1341C>Tp.Phe447Phe
synonymous
Exon 12 of 21NP_001094.1P35609-1
ACTN2
NM_001278343.2
c.1341C>Tp.Phe447Phe
synonymous
Exon 12 of 21NP_001265272.1P35609-2
ACTN2
NR_184402.1
n.1713C>T
non_coding_transcript_exon
Exon 14 of 23

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ACTN2
ENST00000366578.6
TSL:1 MANE Select
c.1341C>Tp.Phe447Phe
synonymous
Exon 12 of 21ENSP00000355537.4P35609-1
ACTN2
ENST00000542672.7
TSL:1
c.1341C>Tp.Phe447Phe
synonymous
Exon 12 of 21ENSP00000443495.1P35609-2
ACTN2
ENST00000879537.1
c.1452C>Tp.Phe484Phe
synonymous
Exon 13 of 22ENSP00000549596.1

Frequencies

GnomAD3 genomes
AF:
0.00210
AC:
320
AN:
152200
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000603
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00196
Gnomad ASJ
AF:
0.0176
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00291
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00258
AC:
648
AN:
251176
AF XY:
0.00253
show subpopulations
Gnomad AFR exome
AF:
0.000677
Gnomad AMR exome
AF:
0.00171
Gnomad ASJ exome
AF:
0.0190
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000462
Gnomad NFE exome
AF:
0.00307
Gnomad OTH exome
AF:
0.00408
GnomAD4 exome
AF:
0.00255
AC:
3735
AN:
1461846
Hom.:
8
Cov.:
32
AF XY:
0.00255
AC XY:
1857
AN XY:
727234
show subpopulations
African (AFR)
AF:
0.000597
AC:
20
AN:
33480
American (AMR)
AF:
0.00215
AC:
96
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.0179
AC:
467
AN:
26124
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000406
AC:
35
AN:
86258
European-Finnish (FIN)
AF:
0.0000749
AC:
4
AN:
53394
Middle Eastern (MID)
AF:
0.00399
AC:
23
AN:
5768
European-Non Finnish (NFE)
AF:
0.00261
AC:
2906
AN:
1112006
Other (OTH)
AF:
0.00305
AC:
184
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
230
460
689
919
1149
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
110
220
330
440
550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00210
AC:
320
AN:
152318
Hom.:
2
Cov.:
32
AF XY:
0.00192
AC XY:
143
AN XY:
74482
show subpopulations
African (AFR)
AF:
0.000601
AC:
25
AN:
41586
American (AMR)
AF:
0.00196
AC:
30
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.0176
AC:
61
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00291
AC:
198
AN:
68024
Other (OTH)
AF:
0.00237
AC:
5
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
20
39
59
78
98
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00375
Hom.:
1
Bravo
AF:
0.00267
EpiCase
AF:
0.00403
EpiControl
AF:
0.00415

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
6
not specified (6)
-
-
4
not provided (4)
-
-
1
ACTN2-related disorder (1)
-
-
1
Cardiomyopathy (1)
-
-
1
Cardiovascular phenotype (1)
-
-
1
Dilated cardiomyopathy 1AA (1)
-
-
1
Primary familial hypertrophic cardiomyopathy;C2677338:Dilated cardiomyopathy 1AA (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.26
CADD
Benign
1.6
DANN
Benign
0.80
PhyloP100
-0.30
Mutation Taster
=90/10
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34785693; hg19: chr1-236908011; COSMIC: COSV63975119; COSMIC: COSV63975119; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.